158 related articles for article (PubMed ID: 3288125)
1. HLA class I antigen (heavy and light chain) expression by Langerhans cells and keratinocytes of the normal human epidermis: ultrastructural quantitation using immunogold labelling procedure.
Gielen V; Schmitt D; Thivolet J
Arch Dermatol Res; 1988; 280(3):131-6. PubMed ID: 3288125
[TBL] [Abstract][Full Text] [Related]
2. Location of HLA-A,B,C antigens in dendritic cells of normal human skin: an immunoelectron microscopic study.
Bronstein BR; Murphy GF; Harrist TJ; Ruiter DJ; Mihm MC; Bhan AK
J Invest Dermatol; 1983 Jun; 80(6):481-4. PubMed ID: 6343512
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of two distinct cell populations expressing HLA-DR antigens in normal human epidermis.
Dezutter-Dambuyant C; Cordier G; Schmitt D; Faure M; Laquoi C; Thivolet J
Br J Dermatol; 1984 Jul; 111(1):1-11. PubMed ID: 6204670
[TBL] [Abstract][Full Text] [Related]
4. Antigen-presenting cells in essential fatty acid-deficient murine epidermis: keratinocytes bearing class II (Ia) antigens may potentiate the accessory cell function of Langerhans cells.
Udey MC; Peck RD; Pentland AP; Schreiner GF; Lefkowith JB
J Invest Dermatol; 1991 Jun; 96(6):950-8. PubMed ID: 1828477
[TBL] [Abstract][Full Text] [Related]
5. HLA-D region antigen expression by human epidermal Langerhans cells.
Sontheimer RD; Stastny P; Nũnez G
J Invest Dermatol; 1986 Dec; 87(6):707-10. PubMed ID: 3537146
[TBL] [Abstract][Full Text] [Related]
6. MHC class II antigen expression in normal human epidermis.
Carr MM; McVittie E; Guy K; Gawkrodger DJ; Hunter JA
Immunology; 1986 Oct; 59(2):223-7. PubMed ID: 2429921
[TBL] [Abstract][Full Text] [Related]
7. Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes.
Basham TY; Nickoloff BJ; Merigan TC; Morhenn VB
J Invest Dermatol; 1984 Aug; 83(2):88-90. PubMed ID: 6206165
[TBL] [Abstract][Full Text] [Related]
8. Epidermal cell populations and antigen expression in cultures of human neonatal epidermis.
Thompson CH; Rose BR; Cossart YE
Aust J Exp Biol Med Sci; 1986 Aug; 64 ( Pt 4)():311-22. PubMed ID: 3098214
[TBL] [Abstract][Full Text] [Related]
9. T-cell response to purified protein derivative after removal of Langerhans' cells from epidermal cell suspensions containing keratinocytes expressing class II transplantation antigens.
Tjernlund U; Scheynius A; Johansson C; Hagforsen E; Nilsson H
Scand J Immunol; 1988 Dec; 28(6):667-73. PubMed ID: 3266023
[TBL] [Abstract][Full Text] [Related]
10. Recent advances of ultrastructural immunocytochemistry of epidermal Langerhans cells.
Schmitt D; Dezutter-Dambuyant C; Faure M; Thivolet J
Br J Dermatol; 1985 Jul; 113 Suppl 28():2-9. PubMed ID: 3925979
[TBL] [Abstract][Full Text] [Related]
11. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
[TBL] [Abstract][Full Text] [Related]
12. Ia+ murine epidermal Langerhans cells are deficient in surface expression of the class I major histocompatibility complex.
Caughman SW; Sharrow SO; Shimada S; Stephany D; Mizuochi T; Rosenberg AS; Katz SI; Singer A
Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7438-42. PubMed ID: 3532113
[TBL] [Abstract][Full Text] [Related]
13. Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens).
Hanau D; Fabre M; Schmitt DA; Garaud JC; Pauly G; Tongio MM; Mayer S; Cazenave JP
Proc Natl Acad Sci U S A; 1987 May; 84(9):2901-5. PubMed ID: 3106979
[TBL] [Abstract][Full Text] [Related]
14. Absence of expression of class II major histocompatibility complex determinants on keratinocytes in bullous pemphigoid.
Venning VA; Dean D; Wojnarowska F
Br J Dermatol; 1992 May; 126(5):463-7. PubMed ID: 1610686
[TBL] [Abstract][Full Text] [Related]
15. HLA class II expression on human epidermal Langerhans cells in situ: upregulation during the elicitation of allergic contact dermatitis.
Mommaas AM; Wijsman MC; Mulder AA; van Praag MC; Vermeer BJ; Koning F
Hum Immunol; 1992 Jun; 34(2):99-106. PubMed ID: 1429038
[TBL] [Abstract][Full Text] [Related]
16. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
Ashworth J; Kahan MC; Breathnach SM
Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
[TBL] [Abstract][Full Text] [Related]
17. The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions.
Sontheimer RD
J Invest Dermatol; 1985 Jul; 85(1 Suppl):21s-26s. PubMed ID: 3159806
[TBL] [Abstract][Full Text] [Related]
18. Femtosecond two-photon high-resolution 3D imaging, spatial-volume rendering and microspectral characterization of immunolocalized MHC-II and mLangerin/CD207 antigens in the mouse epidermis.
Tirlapur UK; Mulholland WJ; Bellhouse BJ; Kendall M; Cornhill JF; Cui Z
Microsc Res Tech; 2006 Oct; 69(10):767-75. PubMed ID: 16941665
[TBL] [Abstract][Full Text] [Related]
19. Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects.
de Jong MC; Blanken R; Nanninga J; Van Voorst Vader PC; Poppema S
J Invest Dermatol; 1986 Dec; 87(6):698-702. PubMed ID: 2431069
[TBL] [Abstract][Full Text] [Related]
20. Methods in laboratory investigation. Immunoelectron microscopic methods for demonstration of antigens on normal human melanocytes and other epidermal cells.
van Duinen SG; Mauw BJ; de Graaff-Reitsma CB; Ruiter DJ
Lab Invest; 1984 Jun; 50(6):733-41. PubMed ID: 6427521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
